Disproportionality analysis of pregnancy janus kinase inhibitor reports in VigiBase

ENTIS affiliated researchers from the Swiss TIS (University of Lausanne/University of Bern), Ente Ospedaliero Cantonale (Lugano) and Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne) have published a disproportionality analysis of the VigiBase World Health Organization global pharmacovigilance database, to identify signals of disproportionate reporting for pregnancy-related adverse drug reactions associated with janus kinase inhibitors. More information is available here. Photo by […]

» Read more

Disproportionality analysis of pregnancy CFTR modulator reports in VigiBase

ENTIS affiliated researchers from the Swiss TIS (University of Lausanne), Ente Ospedaliero Cantonale (Lugano) and Centre Hospitalier Universitaire Vaudois (CHUV, Lausanne) have published a disproportionality analysis of the VigiBase World Health Organization global pharmacovigilance database, to identify signals of disproportionate reporting for pregnancy-related adverse drug reactions associated with elexacaftor, ivacaftor, tezacaftor and lumacaftor. More information is available here. Photo by […]

» Read more

Critical evaluation published on the latest review of neurodevelopmental disorders following in utero exposure to acetaminophen (paracetamol)

Professor Per Damkier (Department of Clinical Pharmacology, Odense University Hospital, Denmark) has produced a critical evaluation of the recent navigation guide review of evidence on acetaminophen (paracetamol) use in pregnancy and neurodevelopmental disorders in the offspring (see the navigation guide review here).

» Read more

Systematic review and meta-analysis of pregnancy outcomes following paternal methotrexate exposure published

Researchers from Izmir TIS (Terafar), the Department of Medical Pharmacology, Marmara University School of Medicine, and the Turkish Medicines and Medical Devices Agency have published a systematic review and meta-analysis of pregnancy outcomes following paternal methotrexate exposure. More information is available here. Photo by Towfiqu barbhuiya, downloaded from Pexels.

» Read more
1 2 3 29